INFO
We are a pre-clinical bio/pharmaceutical company, dedicated to designing and developing first-in-class anti-cancer therapeutics. We are developing platform technology that is focused on eliminating and/or functionally inactivating the cancer cells that initiate tumor development and are responsible for chemo/radiotherapy resistance, tumor relapse, and their spread throughout the body (metastasis).